{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:55:38Z","timestamp":1769583338991,"version":"3.49.0"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T00:00:00Z","timestamp":1252540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:p>Margin status, a major prognostic parameter in oral cancer, was analyzed vis\u2010\u00e0\u2010vis the histopathologic parameters of risk scores and stromal myofibroblasts. Specimens of tongue carcinoma (<jats:italic>n\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>50) were submitted to a risk score assignment consisting of the worst pattern of invasion, lymphocytic infiltration, and perineural invasion. Frequency of stromal myofibroblasts (alpha\u2010smooth muscle actin stain) was assessed. A triple immunostaining assay with E\u2010cadherin, Ki\u201067 and alpha\u2010smooth muscle actin was used to identify carcinoma cells undergoing epithelial\u2013mesenchymal transition. Margins were considered \u2018clean\u2019 if the tumor was \u22655\u2003mm away from them. Patients \u226460\u2003years were considered as \u2018young\u2019. Kaplan\u2013Meier survival analysis with univariate and Cox multivariate regression model with stepwise forward selection, and Fisher\u2019s exact tests were used. Abundant myofibroblasts were found in 27 (54%) cases. Carcinoma cells devoid of E\u2010cadherin but amalgamated with the stromal myofibroblasts were identified in 18 (36%) cases. Local recurrence and overall survival were negatively influenced by abundance of stromal myofibroblasts (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.004 and <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.008, respectively). High\u2010risk scores (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.011), positive margins, and \u2018young\u2019 age (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.027, each) had an unfavorable impact on recurrence. Multivariate analysis revealed that only abundance of stromal myofibroblasts had an independent adverse effect on local recurrence (hazard ratio [HR] 4.369; <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.014; 95% confidence interval [CI], 1.356\u201314.074). It seems that abundant stromal myofibroblasts (camouflaging some malignant cells) and high\u2010risk scores have an unfavorable impact on the risk of recurrence in particular in \u2018young\u2019 patients. Therefore, the treatment concept should be adjusted accordingly and target concomitantly the epithelial malignancy and its allied stroma. (<jats:italic>Cancer Sci<\/jats:italic> 2009)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2009.01357.x","type":"journal-article","created":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T09:17:31Z","timestamp":1252574251000},"page":"274-280","source":"Crossref","is-referenced-by-count":81,"title":["Tumor\u2010host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer"],"prefix":"10.1111","volume":"101","author":[{"given":"Marilena","family":"Vered","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Dobriyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoav P.","family":"Talmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lev","family":"Bedrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Barshack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo","family":"Taicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000149687.90710.21"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1398"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/154405910608501201"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23925"},{"key":"e_1_2_6_6_2","first-page":"72","article-title":"Epithelial\u2013mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic","volume":"1796","author":"Voulgari A","year":"2009","journal-title":"Biochimica Biophysica Acta"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1835"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000084505"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12307-009-0020-0"},{"key":"e_1_2_6_10_2","first-page":"168","volume-title":"World Health Organization Classification of Tumors, Head and Neck Tumours, Pathology and Genetics","author":"Johnson N","year":"2005"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2002.00147.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00125480-199905000-00002"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-008-0054-5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2005.10.018"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.128.3.268"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-006-0111-y"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.11.094"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1054\/ijom.2002.0313"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2008.07.016"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0347(200009)22:6<559::AID-HED3>3.0.CO;2-7"},{"issue":"4","key":"e_1_2_6_21_2","first-page":"2917","article-title":"Occurrence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavorable prognostic factor","volume":"27","author":"Surowiak P","year":"2007","journal-title":"Anticancer Res"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2191"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02873.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21097"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841869609098514"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2007.07.011"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2008.05.009"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21223"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathol.1.110304.100224"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.07.977"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2008.01471.x"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2009.01357.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2009.01357.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T16:24:52Z","timestamp":1698769492000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2009.01357.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1349-7006.2009.01357.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01357.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,9]]}}}